CONGRESS PROGRAM

Wednesday, November 4, 2026

8:00–9:00 — Registration
9:00–9:30 — Opening

Session 1 — Multiomics in Cancer

Chairs: Petar Ozretić, Milena Čavić

• 9:30–10:15 — Plenary Lecture: Carlos Caldas (Israel/UK)
  “Breast Cancer Multiomics: From Biology to Clinical Application” [Sponsored by EACR]
• 10:15–10:35 — Boris Maček (Germany)
  “Personalized Proteomics in Cancer Research”
• 10:35–10:55 — Dilek Pirim (Turkey)
  “Translational Bioinformatics Approaches in Cancer Research”
• 10:55–11:05 — Rosa Karlić (Croatia)
  “OSTEO-ATLAS: Clinical Characterization and Longitudinal Multi-Omic Profiling of Osteosarcoma in a Croatian Cohort”
• 11:05–11:15 — Karla Ostojić (Croatia)
  “From Shape to Size: Comparing Volume Estimation Methods in Osteosarcoma Tumor Spheroids”

11:15–11:45 — Coffee Break

• 11:45–12:05 — Fran Supek (Spain/Denmark)
  “Genomic Language Models for Elucidating DNA Replication, Mutagenesis and RNA Turnover”
• 12:05–12:25 — Morana Jaganjac (Croatia)
  “Redox–Metabolic Crosstalk in Cancer: The Role of Lipid Peroxidation and 4-Hydroxynonenal”
• 12:25–12:35 — Ivan Lučić (Croatia)
  “FOXO1–AQP5–AKT Signaling in SUM159 TNBC Adaptation to Oxidative Stress”
• 12:35–12:45 — Marina Oskomić (Zagreb)
  “Nrf2-Independent Role of Keap1 in Actin Cytoskeleton Regulation in Cancer Cells”
• 12:45–12:55 — Chanchai Boonla (Thailand)
  “MUC19 is Overexpressed in Human Hepatocellular Carcinoma Tissues and Induced by Oxidative Stress in Human Hepatocellular Carcinoma Cell Lines”

12:55–14:10 — Lunch Break

14:10–15:00 — Poster Session 1

Session 2 — Cancer Signaling

• 15:00–15:20 — Anja Uhmann (Germany)
  “Hedgehog Signalling in the Healthy and Diseased Adult Pituitary Gland”
• 15:20–15:40 — Bojana Kožik (Serbia)
  “Extramural Venous Invasion in Rectal Cancer: From Molecular Mechanisms to Therapeutic Opportunities”
• 15:40–16:00 — Nikolina Stojanović (Croatia)
  “Where KANK2 Matters: Deciding Between Migration and Adhesion”
• 16:00–16:10 — Anja Bukovac (Croatia)
  “Differential Activation of Notch and Wnt Signalling Pathways in Meningioma Progression: Association with β-Catenin, APC, NOTCH1/2 and LEF1”
• 16:10–16:20 — Marija Pavlović (Serbia)
  “Integrating Mathematical Modeling and Experimental Studies to Elucidate Doxorubicin Effects in a 3D Osteosarcoma Model”

16:20–16:50 — Coffee Break

• 16:50–17:10 — Ivana Novak Nakir (Croatia)
  “Signaling Networks Governing Receptor-Mediated Mitophagy”
• 17:10–17:30 — Kivanc Gorgulu (Germany)
  “Autophagy and Pancreatic Cancer: From Bench to Bedside”
• 17:30–17:40 — Kristina Vuković Đerfi (Croatia)
  “Dysregulated UFMylation Pathway is Associated with Aggressive Clinical Features and Cancer Stem Cell Phenotypes in Head and Neck Cancer”
• 17:40–17:50 — Katarina Soža (Croatia)
  “Expanding the HPV E6 Interactome: Identification of a Novel PDZ-domain Containing Cellular Target”
• 17:50–18:00 — Fazel Gorjipour (Turkey)
  “Albumin Binding Attenuates the Apparent Cellular Potency of BAY-1816032 in Mesothelioma Models”

18:00–19:00 — Congress Dinner

Thursday, November 5, 2026

Session 3 — Experimental Models in Cancer

• 9:00–9:20 — Raphela Aranie Ranjan (Germany)
  “The Chick Chorioallantoic Membrane Model as a Versatile Platform for Pancreatic Cancer Research: Tumor–Stroma Interactions, Metabolic Imaging, and Therapeutic Evaluation”
• 9:20–9:40 — Aleksandra Divac Rankov (Serbia)
  “Zebrafish Avatars in Personalized Cancer Therapy”
• 9:40–10:00 — Esben Eller (PentaBase A/S, Denmark)
  “A Novel Method for Direct Analysis of DNA Methylation; No Need for Bisulfite Conversion and Pyrosequencing!” [Sponsored by Altium International d.o.o.]
• 10:00–10:10 — Emilija Milošević (Serbia)
  “Effects of Thrombin and Dabigatran on Colorectal Cancer Cells In Vitro and in Zebrafish Xenograft Model”
• 10:10–10:20 — Davor Babič (Slovenia)
  “Evaluation of the Anti-B7-H3 Nanobody Nb63 in 3D and In Vivo Glioblastoma Models”
• 10:20–10:30 — Jelena Dinić (Serbia)
  “A Biomimetic Three-Dimensional Model of Non-Small Cell Lung Cancer in a Perfusion Bioreactor: An Advanced Platform for Anticancer Drug Testing”

10:30–11:00 — Coffee Break [Sponsored by GOREA PLUS d.o.o.]

Session 4 — Inflammation in Cancer

• 11:00–11:20 — Ivana Jovčevska (Slovenia)
  “Beyond Tumor Type: Shared miRNA Regulators of Immune Checkpoint Signaling”
• 11:20–11:40 — Marijana Kovačić (Serbia)
  “Anti-Inflammatory Dietary Intervention in Breast Cancer Patients Receiving Aromatase Inhibitors”
• 11:40–12:00 — Zorica Cvetković (Serbia)
  “Redefining Risk in DLBCL: Beyond the IPI Toward Integrated Precision Prognostication”
• 12:00–12:10 — Ivana Stojanović (Serbia)
  “Timeline of Innate Lymphoid Cell Profiles in Breast Cancer: Insights from Murine Models and Women with Breast Cancer”
• 12:10–12:20 — Miljana Nenkov (Germany)
  “Prognostic Implications of Long-Chain Fatty Acyl-CoA Synthetases (ACSLs) in Colorectal Carcinoma (CRC) and Their Potential Role in Tumor-Adipocyte Crosstalk at the Invasive Front”

12:20–13:30 — Lunch Break

13:30–14:15 — Poster Session 2

Session 5 — Cancer Therapy and Biomarkers

Chairs: Neda Slade, Engin Ulukaya

• 14:15–15:00 — The EMBO Keynote Lecture: Volker Dötsch (Germany)
  “DARPins for Stabilization or Degradation of p53 Mutants”
• 15:00–15:20 — Ivana Galetić (Switzerland)
  “Radioligand Therapy in Oncology”
• 15:20–15:40 — Marta Popović (Croatia)
  “DNA-Protein Crosslink Repair: Mechanisms and Implications for Cancer Therapy”
• 15:40–16:00 — Marija Mojić (Serbia)
  “Rethinking Tumor Cell Death in Colorectal Cancer: Booster for Progression and Target for Therapy”
• 16:00–16:10 — Monika Mlinarić (Croatia)
  “Effects of Olive Leaf Extracts on Doxorubicin Response in Breast Cancer Cells”
• 16:10–16:20 — Ružica Šoić (Croatia)
  “Bismuth-Based Nanoparticles for Potential Radiosensitization: Gamma-Radiolytic Synthesis and Cytotoxicity in HeLa and A431 Cells”

16:20–16:50 — Coffee Break

• 16:50–17:10 — Elif Uz (Turkey)
  “Circular RNAs: Potential Biomarkers in Cancer”
• 17:10–17:30 — Ozlem Er (Turkey)
  “Molecular Testing of Glial Tumors in Adults for Targeted Therapy Selection”
• 17:30–17:40 — Tamara Babić (Serbia)
  “Real-World Clinical Evaluation of Plasma Dynamic Light Scattering in a Tertiary Pulmonology Ward”
• 17:40–17:50 — Melis Kartal Yandim (Turkey)
  “Modulation of Sphingolipid Rheostat Overcomes Asciminib Resistance in Chronic Myeloid Leukemia Cells” [Recorded lecture]

17:50–18:20 — Closing & Awards [Sponsored by EACR, FEBS OpenBio, Molecular Oncology]